INS and type 2 diabetes mellitus: Yang Y et al. suggested that reduced m6A levels in type 2 diabetes patients may contribute to the upregulation of methyltransferases [15], and De Jesus DF et al. demonstrated that METTL14 knockout mice exhibit early-onset diabetes due to decreased β-cell proliferation and insulin secretion [16].